Amgen (AMGN) Tops Q4 EPS by 10c, Offers FY Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PTC
2. NVDA
3. PCVX
4. META
5. MSFT
6. SPY
7. GOOGL
8. GMAB
9. USO
10. AMD

Go back to Amgen (AMGN) Tops Q4 EPS by 10c, Offers FY Guidance

Amgen (AMGN) PT Raised to $202 at BMO Capital Amid Positive Repatha Data

February 3, 2017 6:53 AM EST

BMO Capital raised its price target on Amgen (NASDAQ: AMGN) to $202.00 (from $197.00) while maintaining a Outperform rating following positive Repatha CV outcomes data

Analyst M. Ian Somaiya commented, "Addition of CV outcomes data to the Repatha label and launch of erenumab for migraine... More